XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Net Income Attributable to Shareholders of Crawford & Company per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Schedule of Computations of Basic Net Income Attributable to Shareholders of Crawford & Company per Common Share | The computations of basic net income attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Nine months ended |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
(Loss) earnings per share - basic: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed (loss) earnings |  | $ | (10,647 | ) |  | $ | (7,401 | ) |  | $ | 4,632 |  |  | $ | 3,380 |  |  | $ | (7,797 | ) |  | $ | (5,359 | ) |  | $ | 11,257 |  |  | $ | 8,205 |
Dividends paid |  |  | 1,713 |  |  |  | 1,191 |  |  |  | 1,839 |  |  |  | 1,344 |  |  |  | 5,299 |  |  |  | 3,639 |  |  |  | 5,539 |  |  |  | 4,038 |
Net (loss) income attributable to common shareholders, basic |  | $ | (8,934 | ) |  | $ | (6,210 | ) |  | $ | 6,471 |  |  | $ | 4,724 |  |  | $ | (2,498 | ) |  | $ | (1,720 | ) |  | $ | 16,796 |  |  | $ | 12,243 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 30,711 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 30,786 |  |  |  | 22,438 |
(Loss) earnings per share - basic |  | $ | (0.31 | ) |  | $ | (0.31 | ) |  | $ | 0.21 |  |  | $ | 0.21 |  |  | $ | (0.08 | ) |  | $ | (0.09 | ) |  | $ | 0.55 |  |  | $ | 0.55 |
Schedule of Computations of Diluted Net Income Attributable to Shareholders of Crawford & Company per Common Share | The computations of diluted net income attributable to shareholders of Crawford & Company per common share were as follows:
|  | Three Months Ended |  |  | Nine Months Ended |
|  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
(in thousands, except per share amounts) |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |  |  | CRD-A |  |  | CRD-B |
(Loss) earnings per share - diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Allocation of undistributed (loss) earnings |  | $ | (10,647 | ) |  | $ | (7,401 | ) |  | $ | 4,710 |  |  | $ | 3,302 |  |  | $ | (7,797 | ) |  | $ | (5,359 | ) |  | $ | 11,428 |  |  | $ | 8,034 |
Dividends paid |  |  | 1,713 |  |  |  | 1,191 |  |  |  | 1,839 |  |  |  | 1,344 |  |  |  | 5,299 |  |  |  | 3,639 |  |  |  | 5,539 |  |  |  | 4,038 |
Net (loss) income attributable to common shareholders, diluted |  | $ | (8,934 | ) |  | $ | (6,210 | ) |  | $ | 6,549 |  |  | $ | 4,646 |  |  | $ | (2,498 | ) |  | $ | (1,720 | ) |  | $ | 16,967 |  |  | $ | 12,072 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding, basic |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 30,711 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 30,786 |  |  |  | 22,438 |
Weighted-average effect of dilutive securities |  |  | — |  |  |  | — |  |  |  | 1,243 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,130 |  |  |  | — |
Weighted-average common shares outstanding, diluted |  |  | 28,553 |  |  |  | 19,848 |  |  |  | 31,954 |  |  |  | 22,407 |  |  |  | 29,397 |  |  |  | 20,202 |  |  |  | 31,916 |  |  |  | 22,438 |
(Loss) earnings per share - diluted |  | $ | (0.31 | ) |  | $ | (0.31 | ) |  | $ | 0.20 |  |  | $ | 0.21 |  |  | $ | (0.08 | ) |  | $ | (0.09 | ) |  | $ | 0.53 |  |  | $ | 0.54 |
Schedule of Antidilutive Shares Excluded from Computation of Diluted Earnings per Share | Listed below are the shares excluded from the denominator in the preceding computation of diluted earnings per share for CRD-A because their inclusion would have been antidilutive:
|  | Three Months Ended |  | Nine Months Ended
(in thousands) |  | September 30, 2022 |  | September 30, 2021 |  | September 30, 2022 |  | September 30, 2021
Shares underlying stock options excluded |  | 1,542 |  | 352 |  | 1,542 |  | 706
Performance stock grants excluded because performance conditions have not been met (1) |  | 816 |  | 396 |  | 759 |  | 318
(1) Compensation cost is recognized for these performance stock grants based on expected achievement rates; however, no consideration is given to these performance stock grants when calculating diluted earnings per share until the performance measurements have been achieved.
Schedule of Shares Issued and Included in Weighted-average Common Shares used to Compute Basic and Diluted Earnings per Share | The following table details shares issued during the three and nine months ended September 30, 2022 and 2021, including restricted shares that were returned prior to vesting. These shares are included from their dates of issuance in the weighted-average common shares used to compute basic and diluted earnings per share for CRD-A in the table above. There were no shares of CRD-B issued during any of these periods.
|  | Three Months Ended |  |  | Nine Months Ended |
(in thousands) |  | September 30, 2022 |  |  | September 30, 2021 |  |  | September 30, 2022 |  |  | September 30, 2021 |
CRD-A issued under the Non-Employee Director Stock Plan |  |  | 5 |  |  |  | — |  |  |  | 99 |  |  |  | 67 |
CRD-A issued under the U.K. ShareSave Scheme |  |  | — |  |  |  | 5 |  |  |  | — |  |  |  | 70 |
CRD-A issued under the Employee Stock Purchase Plan |  |  | 124 |  |  |  | 159 |  |  |  | 124 |  |  |  | 159 |
CRD-A issued under the 2016 Omnibus Stock and Incentive Plan |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |

X
- Definition Schedule of shares issued under stock option plans included in weighted-average common shares used to compute basic earnings per share + References No definition available. + Details
Name: | crda_ScheduleOfSharesIssuedUnderStockOptionPlansUsedInWeightedAverageCalculationTableTextBlock
Namespace Prefix: | crda_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the effect of income (loss) on basic earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration